BR9910936A - Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona - Google Patents

Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona

Info

Publication number
BR9910936A
BR9910936A BR9910936-0A BR9910936A BR9910936A BR 9910936 A BR9910936 A BR 9910936A BR 9910936 A BR9910936 A BR 9910936A BR 9910936 A BR9910936 A BR 9910936A
Authority
BR
Brazil
Prior art keywords
toltrazuryl
sulfone
oral application
weight
solid preparations
Prior art date
Application number
BR9910936-0A
Other languages
English (en)
Other versions
BR9910936B1 (pt
Inventor
Matthias Kuhn
Bettina Rohde
Helmut Schnabel
Hans-Christian Mundt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9910936A publication Critical patent/BR9910936A/pt
Publication of BR9910936B1 publication Critical patent/BR9910936B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Patente de Invenção:<B>"PREPARAçõES AQUOSAS SEMI-SóLIDAS PARA A APLICAçãO ORAL DE TOLTRAZURIL-SULFONA"<D>. A presente invenção refere-se a pastas de toltrazuril-sulfona, administráveis de maneira oral, contendo substância ativa em uma concentração de 0,1 - 20% em peso e um tamanho de grão de 1 até 10 x 10^ -6^ m, poli (ácidos acrílicos) com um grau de polimerização de cerca de 3 x 10^ 6^ em uma concentração de 0,1 - 5% em peso, bem como, eventualmente, substâncias conservantes e agentes de manutenção da umidade e o restante para 100% em peso de água.
BRPI9910936-0A 1998-06-02 1999-05-20 pasta de toltrazuril-sulfona e processo para sua preparação. BR9910936B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824483A DE19824483A1 (de) 1998-06-02 1998-06-02 Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
PCT/EP1999/003462 WO1999062519A1 (de) 1998-06-02 1999-05-20 Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon

Publications (2)

Publication Number Publication Date
BR9910936A true BR9910936A (pt) 2001-03-06
BR9910936B1 BR9910936B1 (pt) 2010-11-16

Family

ID=7869584

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9910936-0A BR9910936B1 (pt) 1998-06-02 1999-05-20 pasta de toltrazuril-sulfona e processo para sua preparação.

Country Status (18)

Country Link
US (1) US6436935B1 (pt)
EP (1) EP1091740B1 (pt)
JP (1) JP4958336B2 (pt)
KR (1) KR100717832B1 (pt)
CN (1) CN1137687C (pt)
AT (1) ATE279926T1 (pt)
AU (1) AU756372B2 (pt)
BR (1) BR9910936B1 (pt)
CA (1) CA2333680C (pt)
DE (2) DE19824483A1 (pt)
DK (1) DK1091740T3 (pt)
ES (1) ES2232143T3 (pt)
HK (1) HK1038702B (pt)
HU (1) HU228500B1 (pt)
NZ (1) NZ508513A (pt)
PL (1) PL193534B1 (pt)
PT (1) PT1091740E (pt)
WO (1) WO1999062519A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
DE19519821A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos

Also Published As

Publication number Publication date
CN1304310A (zh) 2001-07-18
EP1091740A1 (de) 2001-04-18
HK1038702B (zh) 2004-12-10
DE59910906D1 (de) 2004-11-25
AU756372B2 (en) 2003-01-09
NZ508513A (en) 2002-09-27
HUP0102007A2 (hu) 2001-11-28
ATE279926T1 (de) 2004-11-15
CA2333680A1 (en) 1999-12-09
JP2002516862A (ja) 2002-06-11
KR20010043453A (ko) 2001-05-25
HU228500B1 (en) 2013-03-28
JP4958336B2 (ja) 2012-06-20
AU4364299A (en) 1999-12-20
PL193534B1 (pl) 2007-02-28
KR100717832B1 (ko) 2007-05-11
DK1091740T3 (da) 2005-01-24
US6436935B1 (en) 2002-08-20
DE19824483A1 (de) 1999-12-09
CN1137687C (zh) 2004-02-11
PT1091740E (pt) 2004-12-31
CA2333680C (en) 2009-05-19
HUP0102007A3 (en) 2003-10-28
PL344329A1 (en) 2001-10-22
BR9910936B1 (pt) 2010-11-16
EP1091740B1 (de) 2004-10-20
WO1999062519A1 (de) 1999-12-09
ES2232143T3 (es) 2005-05-16
HK1038702A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
BR9910936A (pt) Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
CA2201749A1 (en) Stable aqueous alfa interferon solution formulations
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
KR910009243A (ko) 치근막 질환 치료용 서방성 조성물
RU94046143A (ru) Фармацевтическая композиция для лечения глаукомы
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
EP1096922A4 (en) IMPROVED STABLE TOPIC ASCORBIC ACID CONTAINERS
BR0008403A (pt) Formulação farmacêutica para administração oral
ES2340363T3 (es) Metodo y composicion para el tratamiento de la neuropatia diabetica.
TR200003688T1 (tr) Glutation&#39;un absorbsıyonu&#39;nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
BR9707154A (pt) Modulaç o da express o de citocina em th1/th2 por ribavirina e análogos de ribavirina em linfócitos t ativados
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
EP0879597A4 (en) TRANSPARENT AQUEOUS SOLUTION OF SODIUM DICLOFENAC AND MEDICINAL PRODUCTS USED THEREOF
EP2229957A3 (en) Stabilization of aqueous compositions of 18f-isotope labelled 2-fluoro-2-deoxy-d-glucose with ethanol
ES2311641T3 (es) Uso de compuestos que contienen selenito para aplicacion topica o bucal.
DE69513767D1 (de) Pharmazeutische Zusammensetzung in Form eines Gels mit Chondroitinsulfat in Salzform zur oralen Verabreichung
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
ATE268181T1 (de) Pharmazeutische zubereitungen enthaltend alginate
BR0108405A (pt) Agente de ativação de célula
ATE383332T1 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
DK1220678T3 (da) Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin
RU2002117081A (ru) Композиция для ухода за кожей лица и веками
US20040131702A1 (en) Use of selenite or preparation containing selenite for treating wounds

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 47/32, A61K 31/53, A61P 33/02

Ipc: A61K 31/53 (2008.04), A61K 47/32 (2008.04)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/11/2010, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 16.11.2020